We were the first to identify the combination of microfluidics and light responsive polymers being developed by Molecular Vision in London as having the potential of completely revolutionising the Point of Care (PoC) diagnostics market. This lab on a chip diagnostic platform has the potential to produce simple to use compact, low cost, hand held device where the analytical capabilities of a number of standard pieces of laboratory equipment can be duplicated.
The InterNano Directory of Experts and Organizations is a listing of both researchers and research organizations that are engaged in nanomanufacturing.
Abraxis Oncology® is the proprietary pharmaceuticals division of Abraxis BioScience, LLC, an integrated global bio-pharmaceutical company. Abraxis Oncology® is dedicated to the discovery and development of novel cancer therapies that target tumor biological pathways. Our focus is to challenge current standards and develop next-generation therapies that revolutionize the treatment of cancer.
Ablynx is focused on the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins based on single-domain antibody fragments, for a range of serious life-threatening human diseases. Ablynx is developing a portfolio of Nanobody®-based therapeutic programmes in a number of major disease areas, including inflammation, thrombosis, oncology and Alzheimer's disease. The unique structure and stability of Nanobodies® has allowed Ablynx, and its partners, to pursue targets that are typically difficult to reach with conventional antibodies.
A&A Company, Inc., for over 50 years, has been at the forefront of the Thermal Spray Coating industry. We are a unique Plant devoted exclusively to the application of Metal, Ceramic, Cermet and Hardfaced Coatings. Combining this Coating specialization with our complete grinding, lapping and machining capabilities provides you a service unmatched elsewhere.
A&A focuses on thermal spray coatings and nano thermal spray coating using custom designed metal, ceramic, cermet and hard faced materials.
Pixelligent Technologies, LLC is an emerging nanotechnology company developing high performance nanocomposites for mission critical applications in the electronics, industrial, and military markets.
We have developed synthetic methods for a variety of nanocrystals with precisely controlled size and shape. All these nanocrystals have a bandgap in the UV and DUV spectra. We are able to disperse these nanocrystals in a variety of solvents and polymers using capping agents to achieve sufficient loading and uniformity.
eSpin Technologies, Inc. is a high-tech manufacturing company. The company provides global leadership in polymeric nanofiber manufacturing technology applicable across the universe of emergent and traditional manufacturing sectors. eSpin's nanofibers are 20-200nm in diameter, have a very high surface area to mass ratio, and can be formed into membranes with very high porosity.
A123Systems is one of the world's leading suppliers of high-power lithium ion batteries using our patented Nanophosphate™ technology designed to deliver a new combination of power, safety and life.
Our breakthrough technology, innovative multinational manufacturing model and experienced executives are providing the power to change the game for today’s Transportation, Electric Grid Services and Portable Power manufacturers.
Amprius’ immediate goals include commercialization of silicon-based anode materials with 10 times the capacity of current carbon anodes, offering an increase in cell capacity of roughly 40%.
Amprius, Inc., is working to develop a unique, high-throughput, continuous manufacturing process for producing a novel, nanostructured silicon-based anode material for lithium batteries. Higher energy density batteries would have a major impact on the development of electric vehicles by extending driving range and lowering costs.
Liquidia Technologies is developing engineered particle-based vaccines and therapeutics that have the potential to dramatically improve the quality of human life. Utilizing a novel technology known as the PRINT® platform, Liquidia is creating rationally-design carriers for improved delivery of small molecule and biological cargos.